Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Cognitive Remediation in Early Substance Abuse Treatment

This study has been terminated.
(The intervention could not be successfully carried out in the SADP setting because of issues independent of the cognitive training intervention.)
Information provided by:
VA Office of Research and Development Identifier:
First received: June 2, 2006
Last updated: June 17, 2009
Last verified: June 2009
This study is for the purpose of determining whether cognitive remediation may improve cognition and treatment response in patients entering substance abuse day treatment

Condition Intervention
Substance-Related Disorders
Behavioral: Cognitive Remediation

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Cognitive Remediation in the Initial Phase of Substance Abuse Treatment: Feasibility and Efficacy

Resource links provided by NLM:

Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • Cognitive improvement and adherence to substance abuse treatment [ Time Frame: 6 month follow-up ]

Estimated Enrollment: 40
Study Start Date: August 2005
Study Completion Date: December 2008
Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
PSS CogRehab exercises
Behavioral: Cognitive Remediation
PSS Cogrehab
No Intervention: 2
On-line computer games

Detailed Description:

Background: Patients entering substance abuse treatment display cognitive deficits that may reduce their ability to benefit from their treatment. While there is considerable variety in the severity and types of cognitive impairment found in newly recovering patients, problems with attention, memory and executive function are very common. Since treatment requires sustained attention, remembering what is learned, integrating that knowledge and applying it to recovery, impairment in underlying cognitive processes makes successful treatment less likely. Although cognitive functioning improves with sustained sobriety, it is during the early phase of recovery that most patients receive the most intensive treatment. Recent research has suggested that cognitive remediation exercises during this early phase may speed up the return of cognitive functioning and in so doing may have a direct effect on whether patients find the treatment useful and complete their treatment. By keeping patients in treatment longer, cognitive remediation may have an indirect effect on substance abuse outcomes.

Objectives: To pilot test the introduction of cognitive remediation at the Substance Abuse Day Treatment Program (SADP) at the Errara Community Care Center. Aims are 1) to assess the receptivity of patients to the intervention by determining rates of agreement to participate, 2) to determine the number of cognitive remediation sessions that patients are willing to engage in, 3) to assess a variety of cognitive remediation tasks for their acceptability, 4) to evaluate neuropsychological improvements using pre-post assessment, 5) to evaluate its effects on substance abuse treatment participation, and 6) to evaluate its effects on substance abuse outcomes at 6 months follow-up.

Design: Randomized clinical trial of cognitive remediation with an active control condition with observations at baseline, end of treatment and 6-months from intake


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Veterans participating in a substance abuse day treatment program at the Errara Community Center

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00334217

United States, Connecticut
VA Connecticut Health Care System (West Haven)
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
VA Office of Research and Development
Principal Investigator: Morris D Bell, PhD VA Connecticut Health Care System (West Haven)
  More Information

Responsible Party: Bell, Morris - Principal Investigator, Department of Veterans Affairs Identifier: NCT00334217     History of Changes
Other Study ID Numbers: O3108R
Study First Received: June 2, 2006
Last Updated: June 17, 2009

Keywords provided by VA Office of Research and Development:
Psychology: cognitive aspects
Substance-Related Disorders
treatment efficacy

Additional relevant MeSH terms:
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders processed this record on April 21, 2017